Table of Contents
ISRN Radiology
Volume 2013 (2013), Article ID 895287, 4 pages
Clinical Study

B-Mode and Elastosonographic Evaluation to Determine the Reference Elastosonography Values for Cervical Lymph Nodes

1Diskapi Yildirim Beyazit Training and Research Hospital, Department of Radiology, Altındag 06110, Ankara, Turkey
2Ataturk Training and Research Hospital, Department of Radiology, Bilkent Yolu 3. km, Cankaya 06800, Ankara, Turkey

Received 29 May 2013; Accepted 10 July 2013

Academic Editors: K.-P. Chang, G. Crisi, and A. Labate

Copyright © 2013 Aydin Kurt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background. It is crucial to differentiate between reactive and malignant lymphadenopathies. Elastosonography measures the elasticity of the tissue. Having a reference value for benign lymph nodes (LNs) is important in interpretation. The purpose of this study is to determine the reference elastosonography values of cervical LNs. Methods. 97 LNs were evaluated by B-mode and elastosonography. Depth, length, width, length to width ratio, hilar-cortical thickness, strain ratio, and elasticity scores were measured. Results. In 18.6% of the cervical LNs cortical thickness was less than the hilar thickness (group A) and in 81.4% it was equal or more (group B). 69.1% of LNs showed strain ratio (SR) less than 3 (group 1) and 30.9% equal to or more than 3 (group 2). 33% of LNs displayed elasticity score (ES) 1; 30.9% ES 2; 22.7% ES 3, and 13.4% ES 4. There was a significant correlation between thickness ratios and elasticity scores (P: 0.011). A significant correlation was also demonstrated between SR groups and elasticity scores. Conclusion. A simple, reproducible, noninvasive imaging technique for diagnosis of malignant LNs is necessary. Elastosonography can aid in the differentiation of benign versus malignant cervical LNs, thus help reduce the number of unnecessary biopsies for benign processes.